Table 2: Change in hemoglobin and hematocrit in ESRD and chronic HD patients treated with AG.
|
Before |
After |
|||
3rd month |
6th month |
One year |
|||
Hb (g/L) |
1 p |
11.3 ± 0.8 |
11.6 ± 1.9 |
11.5 ± 0.9 |
11.0 ± 1.6 |
|
2 p |
10.3 ± 0.3* |
11.3 ± 1.5 |
11.6 ± 1.7 |
10.9 ± 0.5 |
Ht (%) |
1 p |
34% ± 2% |
35% ± 6% |
35% ± 3% |
33% ± 5% |
|
2 p |
31% ± 1%* |
35% ± 4% |
36% ± 6% |
34% ± 2% |
The data are expressed as mean ± standard deviation.*: P < 0.05 compared between the one powder and the two powders groups
Hb: Hemoglobin; Ht: Hematocrit; 1 p: One powder AG; 2 p: Two powders AG.